The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder

Sheng Yu Lee, Shiou Lan Chen, Yun Hsuan Chang, Shih Heng Chen, Chun Hsieh Chu, San Yuan Huang, Nian Sheng Tzeng, Chen Lin Wang, I. Hui Lee, Tzung Lieh Yeh, Yen Kuang Yang, Ru-Band Lu

研究成果: Article同行評審

27 引文 斯高帕斯(Scopus)

摘要

Dextromethorphan (DM) is a non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist that may be neuroprotective for monoamine neurons. We hypothesized that adding DM to valproate (VPA) treatment would attenuate bipolar disorder (BP) symptoms. We evaluated in BP patients the association between the DRD2/ANKK1 TaqIA polymorphism with treatment response to VPA + add-on DM and to VPA + placebo. This double-blind, stratified, randomized study ran from January 2007 through December 2010. BP patients undergoing regular VPA treatments were randomly assigned to groups given either add-on DM (60 mg/day) (n = 167) or placebo (n = 83) for 12 weeks. The Young Mania Rating Scale (YMRS) and Hamilton Depression Rating Scale (HDRS) were used to evaluate clinical response. The genotypes of the DRD2/ANKK1 TaqIA polymorphisms were determined using polymerase chain reactions plus restriction fragment length polymorphism analysis. To adjust within-subject dependence over repeated assessments, multiple linear regression with generalized estimating equation methods was used to analyze the effects of the DRD2/ANKK1 TaqIA polymorphism on clinical performance. Both groups showed significantly decreased YMRS and HDRS scores after 12 weeks of treatment; the differences between groups were non-significant. Decreases in YMRS scores were greater in patients with the A1A1 (P = 0.004) genotypes than with the A2A2 genotype. We conclude that the DRD2/ANKK1 TaqIA polymorphism influenced responses to DM by decreasing manic symptoms in BP patients.

原文English
頁(從 - 到)295-300
頁數6
期刊Journal of Affective Disorders
138
發行號3
DOIs
出版狀態Published - 2012 5月

All Science Journal Classification (ASJC) codes

  • 臨床心理學
  • 精神病學和心理健康

指紋

深入研究「The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder」主題。共同形成了獨特的指紋。

引用此